Insulet (NASDAQ:PODD – Get Rating) and Medigus (NASDAQ:MDGS – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Insider and Institutional Ownership 9.2% of Medigus shares are held by institutional […]
InfuSystem (NYSE:INFU – Get Rating) and Insulet (NASDAQ:PODD – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 61.4% of InfuSystem shares are held by institutional […]